Dr. Ali Rashidee will Serve a Two-Year Term as Co-Chair of the PSWG
SAN FRANCISCO, Jan. 26 /PRNewswire/ --
*NOTE TO EDITORS: Please note that this release was issued previously on January 22, 2009 containing factual errors which have been corrected herein.
Dr. Ali Rashidee MD, MS, the Director for Safety and Risk Management at Quantros, has been elected Co-Chair for the HL7 Patient Safety Work Group (PSWG). This international healthcare information organization's ongoing mission is to simplify the implementation of interfaces between health care applications for the exchange of key sets of clinical data minimizing the need for custom interface programming and program maintenance. The HL7 PSWG is the body tasked with developing the data interchange standard in the patient safety arena.
Dr. Rashidee has spent a large part of his career enhancing healthcare informatics for the betterment of healthcare safety and quality including tenure as a Co-Chair the HL7 PSWG from 2003-2005. In his current role at Quantros, Dr. Rashidee is responsible for ensuring Quantros Safety and Risk Management (SRM) solutions contain an extensive taxonomy and classification schema in alignment with national and international standards along with the business requirements for managing safety in various settings. More than 900 facilities throughout the United States use the SRM application daily to help reduce preventable medical errors and provide a safer environment of care. As a Co-Chair of the HL7 PSWG, Dr. Rashidee's knowledge and experience in patient safety will help further the group's data interoperability endeavors, both nationally and internationally.
"One of the key factors to improving patient safety is the ability for healthcare leadership to have right data presented across the systems to make clinically and fiscally sound decisions about environment of care and process improvement," according to Dr. Rashidee. "The HL7 PSWG is focused on defining data interchange standards for patient safety that breaks down data silos, facilitates interoperability and enables systems to provide a common language across healthcare technology solutions. I am honored to have been elected as a Co-Chair to help lead this very important endeavor."
"The work of the HL7 PSWG is a vital component for creating system interoperability in the area of patient safety," states Sanjaya Kumar, MD, President and CEO for Quantros. "Dr. Rashidee's experience in clinical informatics and patient safety taxonomy development and management with organizations such as AHRQ, PSO-PPC, NHSN, WHO and the FDA are a perfect complement to this team and its goals."
Quantros provides real-time solutions for safety and risk management, outcomes and performance monitoring, accreditation and compliance and surveillance and decision support for leading healthcare providers throughout the nation. Quantros' Web-based applications and value-added services provide a standard platform that creates actionable knowledge and guided direction to help clients save lives, improve quality and conserve assets. Through a variety of direct sales and vendor partners, more than 2,000 healthcare facilities use Quantros technology solutions every day.
Quantros team members include physicians, nurses and healthcare professionals as well as an experienced team of information technology engineers.
Quantros website: www.quantros.com
Founded in 1987, Health Level Seven, Inc. (www.HL7.org) is a not-for-profit, ANSI accredited standards development organization dedicated to providing a comprehensive framework and related standards for the exchange, integration, sharing and retrieval of electronic health information that supports clinical practice and the management, delivery and evaluation of health services. HL7's more than 2,300 members represent approximately 500 corporate members, which include more than 90 percent of the information systems vendors serving healthcare.
HL7's endeavors are sponsored, in part, by the support of its benefactors: Accenture; Booz Allen Hamilton; Centers for Disease Control and Prevention; Duke Translational Medicine Institute (DTMI); Eclipsys Corporation; Eli Lilly & Company; Epic Systems Corporation; Food and Drug Administration; GE Healthcare Information Technologies; GlaxoSmithKline; IBM; Intel Corporation; InterSystems Corporation; Kaiser Permanente; Lockheed Martin; McKesson Provider Technologies; Microsoft Corporation; NHS Connecting for Health; NICTIZ National Healthcare; Novartis; Oracle Corporation; Partners HealthCare System, Inc.; Pfizer, Inc.; Philips Healthcare; QuadraMed Corporation; Quest Diagnostics Inc.; Sanofi-aventis R&D; Siemens Healthcare; St. Jude Medical; Sunquest Information Systems; Thomson Reuters; the U.S. Department of Defense, Military Health System; and the U.S. Department of Veterans Affairs.
Numerous HL7 Affiliates have been established around the globe including Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, India, Ireland, Italy, Japan, Korea, Mexico, The Netherlands, New Zealand, Singapore, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom and Uruguay.
HL7 Website: www.hl7.org
Copyright©2009 PR Newswire.
All rights reserved